Fitness for Durable Weight Loss
CPET in the GLP-1 Era
For Weight Reduction, Fitness Is the Modifier
GLP-1 receptor agonists have transformed obesity care, but pharmacotherapy alone leaves three critical gaps
CPET gives clinicians a baseline physiologic profile with serial follow-up data, helping calibrate exercise thresholds, monitor Peak VO₂, and track whether microvascular function is improving beyond what the scale shows
The GLP-1 Dilemma
The Cost of Unguided Weight Loss
GLP-1s deliver unprecedented weight reduction, but pivotal trials and post-marketing data now show the quality of weight loss matters as much as the quantity
In STEP-1, lean mass fell 9.7% while fat mass fell 19.3%. Tirzepatide shows similar or greater body-composition shifts in routine care. Lean-mass preservation is now a practical monitoring issue during rapid pharmacologic weight loss
STEP-1 body-composition substudy; 2025 GLP-1 body-composition meta-analysis
STEP-1 extension: ~11.6 percentage-points regained within 1 year of stopping semaglutide. SURMOUNT-4: substantial regain across 52 weeks after tirzepatide withdrawal. Maintenance planning needs to begin before the taper
STEP-1 Extension; SURMOUNT-4 randomized withdrawal trial
Weight loss can improve relative Peak VO₂ partly by lowering the body-weight denominator. CPET helps clinicians separate true cardiorespiratory improvement from scale-driven arithmetic
CKB obesity and serial-CPET framework; AHA CRF scientific statement
“A patient can finish a tele-prescribing intake in eight minutes and have a GLP-1 in hand by evening, without a baseline DEXA, a resistance-training protocol, a titration plan, or a maintenance strategy. Medication is one part of care; the clinical protocol determines whether durable physiology is being built”
The Synergy
Pharmacotherapy + Exercise Outperforms Either Alone
- Efficacy: Faster weight loss with Zone 2 + GLP-1
- Safety: Zone 2 may support lower-dose GLP-1 strategies with fewer side effects
- Pre-conditioning: Starting Zone 2 before GLP-1 therapy can help reduce discontinuation risk and support weight maintenance after stopping
vs -6.8 kg liraglutide alone and -4.1 kg exercise alone (RCT, n=195). The combination arm also delivered stronger cardiometabolic outcomes than either component alone
Lundgren et al., NEJM 2021
Exercise adds a physiologic stimulus that weight loss alone does not provide. Serial CPET tracks whether that stimulus is translating into better Peak VO₂, thresholds, and vascular patterns
CPET-Insight clinical framework
JAMA argues GLP-1 weight-loss care should include aerobic and resistance exercise, with coaching, monitoring, and supervision. CPET supplies the aerobic thresholds; body-composition review supplies the muscle signal
Langland, JAMA 2024
Upgrade Standard GLP-1 Practice
Clinical Precision with CPET-Guided Care
| Clinical Metric | Standard GLP-1 Clinic | CPET-Guided Program |
|---|---|---|
| Weight-Loss Composition | Up to 40% lean mass loss; sarcopenic-obesity risk | Measured thresholds to guide aerobic dose and support lean-mass preservation alongside clinic-directed strength and nutrition planning |
| Exercise Prescription | "Walk 150 min/week"; age-predicted HR zones | Individualized four HR zones anchored to AT and modified by IT status when present |
| Cardiovascular Risk | Assumed to improve with weight loss; not measured | Serially tracked: Peak VO₂, O₂-pulse, VE/VCO₂, IT, and exercise BP response |
| Medication Tolerance / Adherence | Dose escalation based mainly on symptoms and scale response | Exercise pre-conditioning and serial physiologic feedback to support adherence, maintenance and discontinuation planning |
| Microvascular Function | Not assessed | Inducible Threshold (IT) pattern recognized for clinician review and serial follow-up |
| Metabolic Monitoring | Scale weight only | Objective RER (substrate utilization), AT and ventilatory efficiency |
| Long-Term Maintenance | Up to 66% rebound after discontinuation | Serial Peak VO₂ and threshold tracking to confirm the weight-loss plan is building durable physiology after discontinuation |
| Patient Relationship | Medication-centered and difficult to differentiate | Longitudinal, data-driven, enhanced patient engagement and shared decision making with the patient in the driver's seat |
Physiology-Guided Weight Management
Serial CPET Guides the Care Pathway
A clinician-facing pathway from first visit through maintenance planning. Each phase yields documented physiology for the patient, the chart, and clinical decision-making
01
Before or early therapy
Baseline CPET
What physiologic baseline are we trying to improve?
Reviewed Outputs
- Peak VO₂, AT, IT, O₂-pulse and VE/VCO₂
- Inducible Threshold (IT) status and exercise BP response
- Starting phenotype for medication, exercise and body-composition review
02
First prescription cycle
Individualized Exercise Planning
What training dose can this patient actually execute?
Reviewed Outputs
- Zone 2 mapped to the patient’s AT-IT corridor
- Customized mix of Continuous Aerobic Exercise Training (CAET) and High-Intensity Interval Training (HIIT) per ExRx
- Wearable HR targets used to coordinate zone-intensity training sessions
03
Around 3 months
Repeat CPET and Revise
Is the plan building durable physiology beyond the scale?
Reviewed Outputs
- Change in physiological status is informed by changes in Peak VO₂, AT, IT, O₂-pulse and VE/VCO₂ parameters
- Peak VO₂ gains of 20% or more can occur in as little as 3 months, and complete IT reversal is also possible - see the example on the Coronary Physiology page
- ExRx is updated with new HR ranges for Zones 1-4
- Signal for changing exercise dose, adherence strategy and risk-factor focus
04
Taper and maintenance
Documented Off-Ramp
Is there enough physiologic reserve to support maintenance?
Reviewed Outputs
- At least one consecutive CPET should show optimized Peak VO₂ with no IT, or stable IT, with or without attaining goal weight
- Pre-taper review before medication discontinuation is considered. Patient must continue consistent exercise regimen to maintain durable physiology
- Annual maintenance CPET for goal maintenance and precise longitudinal tracking
For Weight-Loss Clinics
From Prescriber to Metabolic Center of Excellence
Integrating CPET helps convert a medication-only model into a longitudinal clinical program built around measured physiology, patient education, and ongoing clinician review
Clinic Model Shift
A measured physiology program patients can understand and clinics can operationalize
The clinic remains the center of care. CPET-Insight adds interpretive support, repeatable testing structure, and a physiologic record that can guide longitudinal weight-management follow-up
Differentiate Beyond Remote Prescribing
Measured CPET data creates an in-clinic physiology workflow around baseline testing, threshold patterns, and serial Peak VO₂ trajectories
Align With Reimbursable and Cash-Pay Care
CPET (CPT 94621) may support clinical-pathway reimbursement where appropriate, while also fitting premium metabolic packages with recurring reassessment
Keep Patients Engaged With Visible Progress
Serial physiology helps patients see whether fitness, thresholds, and vascular patterns are improving beyond what the scale can show
Add CPET Without Owning the Whole Lab Workflow
CPET-Insight provides protocol guidance, QC review, and physician-founded interpretive support for data acquired at your site or a partner site
CPET-ologist Chatbot Support
Specialized CPET guidance clinics can use at the point of care
The CPET-ologist is a clinician-facing chatbot built around a proprietary clinical knowledge base (CKB). It helps clinics review report findings, translate HR zones into practical follow-up, and answer clinical questions in detail to support decision-making
For Patients
Ask Your Clinic About Baseline CPET
A GLP-1 prescription is a powerful tool. CPET adds a measured baseline and follow-up trajectory so your clinic can review whether fitness, exercise thresholds, and microvascular-function patterns are improving beyond what the scale can show
Three Questions to Bring to Your Next Visit
- “What was my baseline Peak VO₂ before I started the medication?” If there is not one, ask whether a CPET would help establish your physiologic baseline
- “Is my exercise plan based on my actual ventilatory thresholds, or an age-based formula?” Measured thresholds can make exercise intensity more specific to your physiology
- “When will we repeat the CPET to confirm my fitness, muscle, and microvascular-function patterns are improving, not just my weight?” A common reassessment point is around 3 months, with annual tracking once stable